Aligos Therapeutics Has Received A Notice Of Allowance For Its Us Patent Application
Couchbase Q3 Adj. EPS $(0.22) Beats $(0.33) Estimate, Sales $38.60M Beat $36.65M Estimate
Couchbase (NASDAQ:BASE) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.33) by 33.33 percent. This is a 24.14 percent increase over losses of $(0.29) per share from the